Pharma & Healthcare
Global Buprenorphine Patches Market Research Report 2026
- Feb 24, 26
- ID: 719916
- Pages: 118
- Figures: 124
- Views: 1
This report delivers a comprehensive overview of the global Buprenorphine Patches market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Buprenorphine Patches. The Buprenorphine Patches market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Buprenorphine Patches market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Buprenorphine Patches manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Mundipharma
Grünenthal GmbH
Purdue Pharma
Teva Pharmaceuticals
Sandoz (a division of Novartis)
Camurus AB
Endo Pharmaceuticals
Pfizer
Mylan (now part of Viatris)
Indivior
Hisamitsu Pharmaceutical Co., Inc.
Alvogen
Segment by Type
<10 Micrograms
≥10 Micrograms
by Application
Hospital
Clinic
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Buprenorphine Patches manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Buprenorphine Patches sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Buprenorphine Patches market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Buprenorphine Patches manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Mundipharma
Grünenthal GmbH
Purdue Pharma
Teva Pharmaceuticals
Sandoz (a division of Novartis)
Camurus AB
Endo Pharmaceuticals
Pfizer
Mylan (now part of Viatris)
Indivior
Hisamitsu Pharmaceutical Co., Inc.
Alvogen
Segment by Type
<10 Micrograms
≥10 Micrograms
by Application
Hospital
Clinic
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Buprenorphine Patches manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Buprenorphine Patches sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Buprenorphine Patches Market Overview
1.1 Product Definition
1.2 Buprenorphine Patches by Type
1.2.1 Global Buprenorphine Patches Market Value by Type: 2025 vs 2032
1.2.2 <10 Micrograms
1.2.3 ≥10 Micrograms
1.3 Buprenorphine Patches by Application
1.3.1 Global Buprenorphine Patches Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Other
1.4 Global Buprenorphine Patches Market Size Estimates and Forecasts
1.4.1 Global Buprenorphine Patches Revenue 2021–2032
1.4.2 Global Buprenorphine Patches Sales 2021–2032
1.4.3 Global Buprenorphine Patches Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Buprenorphine Patches Market Competition by Manufacturers
2.1 Global Buprenorphine Patches Sales Market Share by Manufacturers (2021–2026)
2.2 Global Buprenorphine Patches Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Buprenorphine Patches Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Buprenorphine Patches, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Buprenorphine Patches, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Buprenorphine Patches, Product Types and Applications
2.7 Global Key Manufacturers of Buprenorphine Patches, Date of Entry into the Industry
2.8 Global Buprenorphine Patches Market Competitive Situation and Trends
2.8.1 Global Buprenorphine Patches Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Buprenorphine Patches Players Market Share by Revenue
2.8.3 Global Buprenorphine Patches Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Buprenorphine Patches Market Scenario by Region
3.1 Global Buprenorphine Patches Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Buprenorphine Patches Sales by Region: 2021–2032
3.2.1 Global Buprenorphine Patches Sales by Region: 2021–2026
3.2.2 Global Buprenorphine Patches Sales by Region: 2027–2032
3.3 Global Buprenorphine Patches Revenue by Region: 2021–2032
3.3.1 Global Buprenorphine Patches Revenue by Region: 2021–2026
3.3.2 Global Buprenorphine Patches Revenue by Region: 2027–2032
3.4 North America Buprenorphine Patches Market Facts & Figures by Country
3.4.1 North America Buprenorphine Patches Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Buprenorphine Patches Sales by Country (2021–2032)
3.4.3 North America Buprenorphine Patches Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Buprenorphine Patches Market Facts & Figures by Country
3.5.1 Europe Buprenorphine Patches Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Buprenorphine Patches Sales by Country (2021–2032)
3.5.3 Europe Buprenorphine Patches Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Buprenorphine Patches Market Facts & Figures by Region
3.6.1 Asia Pacific Buprenorphine Patches Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Buprenorphine Patches Sales by Region (2021–2032)
3.6.3 Asia Pacific Buprenorphine Patches Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Buprenorphine Patches Market Facts & Figures by Country
3.7.1 Latin America Buprenorphine Patches Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Buprenorphine Patches Sales by Country (2021–2032)
3.7.3 Latin America Buprenorphine Patches Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Buprenorphine Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Buprenorphine Patches Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Buprenorphine Patches Sales by Country (2021–2032)
3.8.3 Middle East and Africa Buprenorphine Patches Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Buprenorphine Patches Sales by Type (2021–2032)
4.1.1 Global Buprenorphine Patches Sales by Type (2021–2026)
4.1.2 Global Buprenorphine Patches Sales by Type (2027–2032)
4.1.3 Global Buprenorphine Patches Sales Market Share by Type (2021–2032)
4.2 Global Buprenorphine Patches Revenue by Type (2021–2032)
4.2.1 Global Buprenorphine Patches Revenue by Type (2021–2026)
4.2.2 Global Buprenorphine Patches Revenue by Type (2027–2032)
4.2.3 Global Buprenorphine Patches Revenue Market Share by Type (2021–2032)
4.3 Global Buprenorphine Patches Price by Type (2021–2032)
5 Segment by Application
5.1 Global Buprenorphine Patches Sales by Application (2021–2032)
5.1.1 Global Buprenorphine Patches Sales by Application (2021–2026)
5.1.2 Global Buprenorphine Patches Sales by Application (2027–2032)
5.1.3 Global Buprenorphine Patches Sales Market Share by Application (2021–2032)
5.2 Global Buprenorphine Patches Revenue by Application (2021–2032)
5.2.1 Global Buprenorphine Patches Revenue by Application (2021–2026)
5.2.2 Global Buprenorphine Patches Revenue by Application (2027–2032)
5.2.3 Global Buprenorphine Patches Revenue Market Share by Application (2021–2032)
5.3 Global Buprenorphine Patches Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Mundipharma
6.1.1 Mundipharma Company Information
6.1.2 Mundipharma Description and Business Overview
6.1.3 Mundipharma Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Mundipharma Buprenorphine Patches Product Portfolio
6.1.5 Mundipharma Recent Developments/Updates
6.2 Grünenthal GmbH
6.2.1 Grünenthal GmbH Company Information
6.2.2 Grünenthal GmbH Description and Business Overview
6.2.3 Grünenthal GmbH Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Grünenthal GmbH Buprenorphine Patches Product Portfolio
6.2.5 Grünenthal GmbH Recent Developments/Updates
6.3 Purdue Pharma
6.3.1 Purdue Pharma Company Information
6.3.2 Purdue Pharma Description and Business Overview
6.3.3 Purdue Pharma Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Purdue Pharma Buprenorphine Patches Product Portfolio
6.3.5 Purdue Pharma Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Company Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Teva Pharmaceuticals Buprenorphine Patches Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Sandoz (a division of Novartis)
6.5.1 Sandoz (a division of Novartis) Company Information
6.5.2 Sandoz (a division of Novartis) Description and Business Overview
6.5.3 Sandoz (a division of Novartis) Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sandoz (a division of Novartis) Buprenorphine Patches Product Portfolio
6.5.5 Sandoz (a division of Novartis) Recent Developments/Updates
6.6 Camurus AB
6.6.1 Camurus AB Company Information
6.6.2 Camurus AB Description and Business Overview
6.6.3 Camurus AB Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Camurus AB Buprenorphine Patches Product Portfolio
6.6.5 Camurus AB Recent Developments/Updates
6.7 Endo Pharmaceuticals
6.7.1 Endo Pharmaceuticals Company Information
6.7.2 Endo Pharmaceuticals Description and Business Overview
6.7.3 Endo Pharmaceuticals Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Endo Pharmaceuticals Buprenorphine Patches Product Portfolio
6.7.5 Endo Pharmaceuticals Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Pfizer Buprenorphine Patches Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Mylan (now part of Viatris)
6.9.1 Mylan (now part of Viatris) Company Information
6.9.2 Mylan (now part of Viatris) Description and Business Overview
6.9.3 Mylan (now part of Viatris) Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Mylan (now part of Viatris) Buprenorphine Patches Product Portfolio
6.9.5 Mylan (now part of Viatris) Recent Developments/Updates
6.10 Indivior
6.10.1 Indivior Company Information
6.10.2 Indivior Description and Business Overview
6.10.3 Indivior Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Indivior Buprenorphine Patches Product Portfolio
6.10.5 Indivior Recent Developments/Updates
6.11 Hisamitsu Pharmaceutical Co., Inc.
6.11.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
6.11.2 Hisamitsu Pharmaceutical Co., Inc. Description and Business Overview
6.11.3 Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Product Portfolio
6.11.5 Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
6.12 Alvogen
6.12.1 Alvogen Company Information
6.12.2 Alvogen Description and Business Overview
6.12.3 Alvogen Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Alvogen Buprenorphine Patches Product Portfolio
6.12.5 Alvogen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Buprenorphine Patches Industry Chain Analysis
7.2 Buprenorphine Patches Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Buprenorphine Patches Production Mode & Process Analysis
7.4 Buprenorphine Patches Sales and Marketing
7.4.1 Buprenorphine Patches Sales Channels
7.4.2 Buprenorphine Patches Distributors
7.5 Buprenorphine Patches Customer Analysis
8 Buprenorphine Patches Market Dynamics
8.1 Buprenorphine Patches Industry Trends
8.2 Buprenorphine Patches Market Drivers
8.3 Buprenorphine Patches Market Challenges
8.4 Buprenorphine Patches Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Buprenorphine Patches by Type
1.2.1 Global Buprenorphine Patches Market Value by Type: 2025 vs 2032
1.2.2 <10 Micrograms
1.2.3 ≥10 Micrograms
1.3 Buprenorphine Patches by Application
1.3.1 Global Buprenorphine Patches Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Other
1.4 Global Buprenorphine Patches Market Size Estimates and Forecasts
1.4.1 Global Buprenorphine Patches Revenue 2021–2032
1.4.2 Global Buprenorphine Patches Sales 2021–2032
1.4.3 Global Buprenorphine Patches Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Buprenorphine Patches Market Competition by Manufacturers
2.1 Global Buprenorphine Patches Sales Market Share by Manufacturers (2021–2026)
2.2 Global Buprenorphine Patches Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Buprenorphine Patches Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Buprenorphine Patches, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Buprenorphine Patches, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Buprenorphine Patches, Product Types and Applications
2.7 Global Key Manufacturers of Buprenorphine Patches, Date of Entry into the Industry
2.8 Global Buprenorphine Patches Market Competitive Situation and Trends
2.8.1 Global Buprenorphine Patches Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Buprenorphine Patches Players Market Share by Revenue
2.8.3 Global Buprenorphine Patches Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Buprenorphine Patches Market Scenario by Region
3.1 Global Buprenorphine Patches Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Buprenorphine Patches Sales by Region: 2021–2032
3.2.1 Global Buprenorphine Patches Sales by Region: 2021–2026
3.2.2 Global Buprenorphine Patches Sales by Region: 2027–2032
3.3 Global Buprenorphine Patches Revenue by Region: 2021–2032
3.3.1 Global Buprenorphine Patches Revenue by Region: 2021–2026
3.3.2 Global Buprenorphine Patches Revenue by Region: 2027–2032
3.4 North America Buprenorphine Patches Market Facts & Figures by Country
3.4.1 North America Buprenorphine Patches Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Buprenorphine Patches Sales by Country (2021–2032)
3.4.3 North America Buprenorphine Patches Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Buprenorphine Patches Market Facts & Figures by Country
3.5.1 Europe Buprenorphine Patches Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Buprenorphine Patches Sales by Country (2021–2032)
3.5.3 Europe Buprenorphine Patches Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Buprenorphine Patches Market Facts & Figures by Region
3.6.1 Asia Pacific Buprenorphine Patches Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Buprenorphine Patches Sales by Region (2021–2032)
3.6.3 Asia Pacific Buprenorphine Patches Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Buprenorphine Patches Market Facts & Figures by Country
3.7.1 Latin America Buprenorphine Patches Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Buprenorphine Patches Sales by Country (2021–2032)
3.7.3 Latin America Buprenorphine Patches Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Buprenorphine Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Buprenorphine Patches Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Buprenorphine Patches Sales by Country (2021–2032)
3.8.3 Middle East and Africa Buprenorphine Patches Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Buprenorphine Patches Sales by Type (2021–2032)
4.1.1 Global Buprenorphine Patches Sales by Type (2021–2026)
4.1.2 Global Buprenorphine Patches Sales by Type (2027–2032)
4.1.3 Global Buprenorphine Patches Sales Market Share by Type (2021–2032)
4.2 Global Buprenorphine Patches Revenue by Type (2021–2032)
4.2.1 Global Buprenorphine Patches Revenue by Type (2021–2026)
4.2.2 Global Buprenorphine Patches Revenue by Type (2027–2032)
4.2.3 Global Buprenorphine Patches Revenue Market Share by Type (2021–2032)
4.3 Global Buprenorphine Patches Price by Type (2021–2032)
5 Segment by Application
5.1 Global Buprenorphine Patches Sales by Application (2021–2032)
5.1.1 Global Buprenorphine Patches Sales by Application (2021–2026)
5.1.2 Global Buprenorphine Patches Sales by Application (2027–2032)
5.1.3 Global Buprenorphine Patches Sales Market Share by Application (2021–2032)
5.2 Global Buprenorphine Patches Revenue by Application (2021–2032)
5.2.1 Global Buprenorphine Patches Revenue by Application (2021–2026)
5.2.2 Global Buprenorphine Patches Revenue by Application (2027–2032)
5.2.3 Global Buprenorphine Patches Revenue Market Share by Application (2021–2032)
5.3 Global Buprenorphine Patches Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Mundipharma
6.1.1 Mundipharma Company Information
6.1.2 Mundipharma Description and Business Overview
6.1.3 Mundipharma Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Mundipharma Buprenorphine Patches Product Portfolio
6.1.5 Mundipharma Recent Developments/Updates
6.2 Grünenthal GmbH
6.2.1 Grünenthal GmbH Company Information
6.2.2 Grünenthal GmbH Description and Business Overview
6.2.3 Grünenthal GmbH Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Grünenthal GmbH Buprenorphine Patches Product Portfolio
6.2.5 Grünenthal GmbH Recent Developments/Updates
6.3 Purdue Pharma
6.3.1 Purdue Pharma Company Information
6.3.2 Purdue Pharma Description and Business Overview
6.3.3 Purdue Pharma Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Purdue Pharma Buprenorphine Patches Product Portfolio
6.3.5 Purdue Pharma Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Company Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Teva Pharmaceuticals Buprenorphine Patches Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Sandoz (a division of Novartis)
6.5.1 Sandoz (a division of Novartis) Company Information
6.5.2 Sandoz (a division of Novartis) Description and Business Overview
6.5.3 Sandoz (a division of Novartis) Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sandoz (a division of Novartis) Buprenorphine Patches Product Portfolio
6.5.5 Sandoz (a division of Novartis) Recent Developments/Updates
6.6 Camurus AB
6.6.1 Camurus AB Company Information
6.6.2 Camurus AB Description and Business Overview
6.6.3 Camurus AB Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Camurus AB Buprenorphine Patches Product Portfolio
6.6.5 Camurus AB Recent Developments/Updates
6.7 Endo Pharmaceuticals
6.7.1 Endo Pharmaceuticals Company Information
6.7.2 Endo Pharmaceuticals Description and Business Overview
6.7.3 Endo Pharmaceuticals Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Endo Pharmaceuticals Buprenorphine Patches Product Portfolio
6.7.5 Endo Pharmaceuticals Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Pfizer Buprenorphine Patches Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Mylan (now part of Viatris)
6.9.1 Mylan (now part of Viatris) Company Information
6.9.2 Mylan (now part of Viatris) Description and Business Overview
6.9.3 Mylan (now part of Viatris) Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Mylan (now part of Viatris) Buprenorphine Patches Product Portfolio
6.9.5 Mylan (now part of Viatris) Recent Developments/Updates
6.10 Indivior
6.10.1 Indivior Company Information
6.10.2 Indivior Description and Business Overview
6.10.3 Indivior Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Indivior Buprenorphine Patches Product Portfolio
6.10.5 Indivior Recent Developments/Updates
6.11 Hisamitsu Pharmaceutical Co., Inc.
6.11.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
6.11.2 Hisamitsu Pharmaceutical Co., Inc. Description and Business Overview
6.11.3 Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Product Portfolio
6.11.5 Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
6.12 Alvogen
6.12.1 Alvogen Company Information
6.12.2 Alvogen Description and Business Overview
6.12.3 Alvogen Buprenorphine Patches Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Alvogen Buprenorphine Patches Product Portfolio
6.12.5 Alvogen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Buprenorphine Patches Industry Chain Analysis
7.2 Buprenorphine Patches Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Buprenorphine Patches Production Mode & Process Analysis
7.4 Buprenorphine Patches Sales and Marketing
7.4.1 Buprenorphine Patches Sales Channels
7.4.2 Buprenorphine Patches Distributors
7.5 Buprenorphine Patches Customer Analysis
8 Buprenorphine Patches Market Dynamics
8.1 Buprenorphine Patches Industry Trends
8.2 Buprenorphine Patches Market Drivers
8.3 Buprenorphine Patches Market Challenges
8.4 Buprenorphine Patches Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Buprenorphine Patches Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Buprenorphine Patches Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Buprenorphine Patches Market Competitive Situation by Manufacturers in 2025
Table 4. Global Buprenorphine Patches Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Buprenorphine Patches Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Buprenorphine Patches Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Buprenorphine Patches Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Buprenorphine Patches Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Buprenorphine Patches, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Buprenorphine Patches, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Buprenorphine Patches, Product Types and Applications
Table 12. Global Key Manufacturers of Buprenorphine Patches, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Buprenorphine Patches Companies by Tier (Tier 1, Tier 2, Tier 3), based on Buprenorphine Patches Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Buprenorphine Patches Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Buprenorphine Patches Sales by Region (K Units), 2021–2026
Table 18. Global Buprenorphine Patches Sales Market Share by Region (2021–2026)
Table 19. Global Buprenorphine Patches Sales by Region (K Units), 2027–2032
Table 20. Global Buprenorphine Patches Sales Market Share by Region (2027–2032)
Table 21. Global Buprenorphine Patches Revenue by Region (US$ Million), 2021–2026
Table 22. Global Buprenorphine Patches Revenue Market Share by Region (2021–2026)
Table 23. Global Buprenorphine Patches Revenue by Region (US$ Million), 2027–2032
Table 24. Global Buprenorphine Patches Revenue Market Share by Region (2027–2032)
Table 25. North America Buprenorphine Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Buprenorphine Patches Sales by Country (K Units), 2021–2026
Table 27. North America Buprenorphine Patches Sales by Country (K Units), 2027–2032
Table 28. North America Buprenorphine Patches Revenue by Country (US$ Million), 2021–2026
Table 29. North America Buprenorphine Patches Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Buprenorphine Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Buprenorphine Patches Sales by Country (K Units), 2021–2026
Table 32. Europe Buprenorphine Patches Sales by Country (K Units), 2027–2032
Table 33. Europe Buprenorphine Patches Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Buprenorphine Patches Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Buprenorphine Patches Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Buprenorphine Patches Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Buprenorphine Patches Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Buprenorphine Patches Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Buprenorphine Patches Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Buprenorphine Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Buprenorphine Patches Sales by Country (K Units), 2021–2026
Table 42. Latin America Buprenorphine Patches Sales by Country (K Units), 2027–2032
Table 43. Latin America Buprenorphine Patches Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Buprenorphine Patches Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Buprenorphine Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Buprenorphine Patches Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Buprenorphine Patches Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Buprenorphine Patches Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Buprenorphine Patches Revenue by Country (US$ Million), 2027–2032
Table 50. Global Buprenorphine Patches Sales (K Units) by Type (2021–2026)
Table 51. Global Buprenorphine Patches Sales (K Units) by Type (2027–2032)
Table 52. Global Buprenorphine Patches Sales Market Share by Type (2021–2026)
Table 53. Global Buprenorphine Patches Sales Market Share by Type (2027–2032)
Table 54. Global Buprenorphine Patches Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Buprenorphine Patches Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Buprenorphine Patches Revenue Market Share by Type (2021–2026)
Table 57. Global Buprenorphine Patches Revenue Market Share by Type (2027–2032)
Table 58. Global Buprenorphine Patches Price (US$/Unit) by Type (2021–2026)
Table 59. Global Buprenorphine Patches Price (US$/Unit) by Type (2027–2032)
Table 60. Global Buprenorphine Patches Sales (K Units) by Application (2021–2026)
Table 61. Global Buprenorphine Patches Sales (K Units) by Application (2027–2032)
Table 62. Global Buprenorphine Patches Sales Market Share by Application (2021–2026)
Table 63. Global Buprenorphine Patches Sales Market Share by Application (2027–2032)
Table 64. Global Buprenorphine Patches Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Buprenorphine Patches Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Buprenorphine Patches Revenue Market Share by Application (2021–2026)
Table 67. Global Buprenorphine Patches Revenue Market Share by Application (2027–2032)
Table 68. Global Buprenorphine Patches Price (US$/Unit) by Application (2021–2026)
Table 69. Global Buprenorphine Patches Price (US$/Unit) by Application (2027–2032)
Table 70. Mundipharma Company Information
Table 71. Mundipharma Description and Business Overview
Table 72. Mundipharma Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Mundipharma Buprenorphine Patches Product
Table 74. Mundipharma Recent Developments/Updates
Table 75. Grünenthal GmbH Company Information
Table 76. Grünenthal GmbH Description and Business Overview
Table 77. Grünenthal GmbH Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Grünenthal GmbH Buprenorphine Patches Product
Table 79. Grünenthal GmbH Recent Developments/Updates
Table 80. Purdue Pharma Company Information
Table 81. Purdue Pharma Description and Business Overview
Table 82. Purdue Pharma Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Purdue Pharma Buprenorphine Patches Product
Table 84. Purdue Pharma Recent Developments/Updates
Table 85. Teva Pharmaceuticals Company Information
Table 86. Teva Pharmaceuticals Description and Business Overview
Table 87. Teva Pharmaceuticals Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Teva Pharmaceuticals Buprenorphine Patches Product
Table 89. Teva Pharmaceuticals Recent Developments/Updates
Table 90. Sandoz (a division of Novartis) Company Information
Table 91. Sandoz (a division of Novartis) Description and Business Overview
Table 92. Sandoz (a division of Novartis) Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Sandoz (a division of Novartis) Buprenorphine Patches Product
Table 94. Sandoz (a division of Novartis) Recent Developments/Updates
Table 95. Camurus AB Company Information
Table 96. Camurus AB Description and Business Overview
Table 97. Camurus AB Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Camurus AB Buprenorphine Patches Product
Table 99. Camurus AB Recent Developments/Updates
Table 100. Endo Pharmaceuticals Company Information
Table 101. Endo Pharmaceuticals Description and Business Overview
Table 102. Endo Pharmaceuticals Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Endo Pharmaceuticals Buprenorphine Patches Product
Table 104. Endo Pharmaceuticals Recent Developments/Updates
Table 105. Pfizer Company Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Pfizer Buprenorphine Patches Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Mylan (now part of Viatris) Company Information
Table 111. Mylan (now part of Viatris) Description and Business Overview
Table 112. Mylan (now part of Viatris) Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Mylan (now part of Viatris) Buprenorphine Patches Product
Table 114. Mylan (now part of Viatris) Recent Developments/Updates
Table 115. Indivior Company Information
Table 116. Indivior Description and Business Overview
Table 117. Indivior Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Indivior Buprenorphine Patches Product
Table 119. Indivior Recent Developments/Updates
Table 120. Hisamitsu Pharmaceutical Co., Inc. Company Information
Table 121. Hisamitsu Pharmaceutical Co., Inc. Description and Business Overview
Table 122. Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Product
Table 124. Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
Table 125. Alvogen Company Information
Table 126. Alvogen Description and Business Overview
Table 127. Alvogen Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Alvogen Buprenorphine Patches Product
Table 129. Alvogen Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Buprenorphine Patches Distributors List
Table 133. Buprenorphine Patches Customers List
Table 134. Buprenorphine Patches Market Trends
Table 135. Buprenorphine Patches Market Drivers
Table 136. Buprenorphine Patches Market Challenges
Table 137. Buprenorphine Patches Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Buprenorphine Patches
Figure 2. Global Buprenorphine Patches Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Buprenorphine Patches Market Share by Type: 2025 & 2032
Figure 4. <10 Micrograms Product Picture
Figure 5. ≥10 Micrograms Product Picture
Figure 6. Global Buprenorphine Patches Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Buprenorphine Patches Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Pharmacy
Figure 11. Other
Figure 12. Global Buprenorphine Patches Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Buprenorphine Patches Market Size (US$ Million), 2021–2032
Figure 14. Global Buprenorphine Patches Sales (K Units), 2021–2032
Figure 15. Global Buprenorphine Patches Average Price (US$/Unit), 2021–2032
Figure 16. Buprenorphine Patches Report Years Considered
Figure 17. Buprenorphine Patches Sales Share by Manufacturers in 2025
Figure 18. Global Buprenorphine Patches Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Buprenorphine Patches Players: Market Share by Revenue in Buprenorphine Patches in 2025
Figure 20. Buprenorphine Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Buprenorphine Patches Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Buprenorphine Patches Sales Market Share by Country (2021–2032)
Figure 23. North America Buprenorphine Patches Revenue Market Share by Country (2021–2032)
Figure 24. United States Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Buprenorphine Patches Sales Market Share by Country (2021–2032)
Figure 27. Europe Buprenorphine Patches Revenue Market Share by Country (2021–2032)
Figure 28. Germany Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Buprenorphine Patches Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Buprenorphine Patches Revenue Market Share by Region (2021–2032)
Figure 35. China Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Buprenorphine Patches Sales Market Share by Country (2021–2032)
Figure 43. Latin America Buprenorphine Patches Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Buprenorphine Patches Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Buprenorphine Patches Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Buprenorphine Patches by Type (2021–2032)
Figure 54. Global Revenue Market Share of Buprenorphine Patches by Type (2021–2032)
Figure 55. Global Buprenorphine Patches Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Buprenorphine Patches by Application (2021–2032)
Figure 57. Global Revenue Market Share of Buprenorphine Patches by Application (2021–2032)
Figure 58. Global Buprenorphine Patches Price (US$/Unit) by Application (2021–2032)
Figure 59. Buprenorphine Patches Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Buprenorphine Patches Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Buprenorphine Patches Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Buprenorphine Patches Market Competitive Situation by Manufacturers in 2025
Table 4. Global Buprenorphine Patches Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Buprenorphine Patches Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Buprenorphine Patches Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Buprenorphine Patches Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Buprenorphine Patches Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Buprenorphine Patches, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Buprenorphine Patches, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Buprenorphine Patches, Product Types and Applications
Table 12. Global Key Manufacturers of Buprenorphine Patches, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Buprenorphine Patches Companies by Tier (Tier 1, Tier 2, Tier 3), based on Buprenorphine Patches Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Buprenorphine Patches Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Buprenorphine Patches Sales by Region (K Units), 2021–2026
Table 18. Global Buprenorphine Patches Sales Market Share by Region (2021–2026)
Table 19. Global Buprenorphine Patches Sales by Region (K Units), 2027–2032
Table 20. Global Buprenorphine Patches Sales Market Share by Region (2027–2032)
Table 21. Global Buprenorphine Patches Revenue by Region (US$ Million), 2021–2026
Table 22. Global Buprenorphine Patches Revenue Market Share by Region (2021–2026)
Table 23. Global Buprenorphine Patches Revenue by Region (US$ Million), 2027–2032
Table 24. Global Buprenorphine Patches Revenue Market Share by Region (2027–2032)
Table 25. North America Buprenorphine Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Buprenorphine Patches Sales by Country (K Units), 2021–2026
Table 27. North America Buprenorphine Patches Sales by Country (K Units), 2027–2032
Table 28. North America Buprenorphine Patches Revenue by Country (US$ Million), 2021–2026
Table 29. North America Buprenorphine Patches Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Buprenorphine Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Buprenorphine Patches Sales by Country (K Units), 2021–2026
Table 32. Europe Buprenorphine Patches Sales by Country (K Units), 2027–2032
Table 33. Europe Buprenorphine Patches Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Buprenorphine Patches Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Buprenorphine Patches Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Buprenorphine Patches Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Buprenorphine Patches Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Buprenorphine Patches Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Buprenorphine Patches Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Buprenorphine Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Buprenorphine Patches Sales by Country (K Units), 2021–2026
Table 42. Latin America Buprenorphine Patches Sales by Country (K Units), 2027–2032
Table 43. Latin America Buprenorphine Patches Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Buprenorphine Patches Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Buprenorphine Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Buprenorphine Patches Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Buprenorphine Patches Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Buprenorphine Patches Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Buprenorphine Patches Revenue by Country (US$ Million), 2027–2032
Table 50. Global Buprenorphine Patches Sales (K Units) by Type (2021–2026)
Table 51. Global Buprenorphine Patches Sales (K Units) by Type (2027–2032)
Table 52. Global Buprenorphine Patches Sales Market Share by Type (2021–2026)
Table 53. Global Buprenorphine Patches Sales Market Share by Type (2027–2032)
Table 54. Global Buprenorphine Patches Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Buprenorphine Patches Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Buprenorphine Patches Revenue Market Share by Type (2021–2026)
Table 57. Global Buprenorphine Patches Revenue Market Share by Type (2027–2032)
Table 58. Global Buprenorphine Patches Price (US$/Unit) by Type (2021–2026)
Table 59. Global Buprenorphine Patches Price (US$/Unit) by Type (2027–2032)
Table 60. Global Buprenorphine Patches Sales (K Units) by Application (2021–2026)
Table 61. Global Buprenorphine Patches Sales (K Units) by Application (2027–2032)
Table 62. Global Buprenorphine Patches Sales Market Share by Application (2021–2026)
Table 63. Global Buprenorphine Patches Sales Market Share by Application (2027–2032)
Table 64. Global Buprenorphine Patches Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Buprenorphine Patches Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Buprenorphine Patches Revenue Market Share by Application (2021–2026)
Table 67. Global Buprenorphine Patches Revenue Market Share by Application (2027–2032)
Table 68. Global Buprenorphine Patches Price (US$/Unit) by Application (2021–2026)
Table 69. Global Buprenorphine Patches Price (US$/Unit) by Application (2027–2032)
Table 70. Mundipharma Company Information
Table 71. Mundipharma Description and Business Overview
Table 72. Mundipharma Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Mundipharma Buprenorphine Patches Product
Table 74. Mundipharma Recent Developments/Updates
Table 75. Grünenthal GmbH Company Information
Table 76. Grünenthal GmbH Description and Business Overview
Table 77. Grünenthal GmbH Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Grünenthal GmbH Buprenorphine Patches Product
Table 79. Grünenthal GmbH Recent Developments/Updates
Table 80. Purdue Pharma Company Information
Table 81. Purdue Pharma Description and Business Overview
Table 82. Purdue Pharma Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Purdue Pharma Buprenorphine Patches Product
Table 84. Purdue Pharma Recent Developments/Updates
Table 85. Teva Pharmaceuticals Company Information
Table 86. Teva Pharmaceuticals Description and Business Overview
Table 87. Teva Pharmaceuticals Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Teva Pharmaceuticals Buprenorphine Patches Product
Table 89. Teva Pharmaceuticals Recent Developments/Updates
Table 90. Sandoz (a division of Novartis) Company Information
Table 91. Sandoz (a division of Novartis) Description and Business Overview
Table 92. Sandoz (a division of Novartis) Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Sandoz (a division of Novartis) Buprenorphine Patches Product
Table 94. Sandoz (a division of Novartis) Recent Developments/Updates
Table 95. Camurus AB Company Information
Table 96. Camurus AB Description and Business Overview
Table 97. Camurus AB Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Camurus AB Buprenorphine Patches Product
Table 99. Camurus AB Recent Developments/Updates
Table 100. Endo Pharmaceuticals Company Information
Table 101. Endo Pharmaceuticals Description and Business Overview
Table 102. Endo Pharmaceuticals Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Endo Pharmaceuticals Buprenorphine Patches Product
Table 104. Endo Pharmaceuticals Recent Developments/Updates
Table 105. Pfizer Company Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Pfizer Buprenorphine Patches Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Mylan (now part of Viatris) Company Information
Table 111. Mylan (now part of Viatris) Description and Business Overview
Table 112. Mylan (now part of Viatris) Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Mylan (now part of Viatris) Buprenorphine Patches Product
Table 114. Mylan (now part of Viatris) Recent Developments/Updates
Table 115. Indivior Company Information
Table 116. Indivior Description and Business Overview
Table 117. Indivior Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Indivior Buprenorphine Patches Product
Table 119. Indivior Recent Developments/Updates
Table 120. Hisamitsu Pharmaceutical Co., Inc. Company Information
Table 121. Hisamitsu Pharmaceutical Co., Inc. Description and Business Overview
Table 122. Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Product
Table 124. Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
Table 125. Alvogen Company Information
Table 126. Alvogen Description and Business Overview
Table 127. Alvogen Buprenorphine Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Alvogen Buprenorphine Patches Product
Table 129. Alvogen Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Buprenorphine Patches Distributors List
Table 133. Buprenorphine Patches Customers List
Table 134. Buprenorphine Patches Market Trends
Table 135. Buprenorphine Patches Market Drivers
Table 136. Buprenorphine Patches Market Challenges
Table 137. Buprenorphine Patches Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Buprenorphine Patches
Figure 2. Global Buprenorphine Patches Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Buprenorphine Patches Market Share by Type: 2025 & 2032
Figure 4. <10 Micrograms Product Picture
Figure 5. ≥10 Micrograms Product Picture
Figure 6. Global Buprenorphine Patches Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Buprenorphine Patches Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Pharmacy
Figure 11. Other
Figure 12. Global Buprenorphine Patches Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Buprenorphine Patches Market Size (US$ Million), 2021–2032
Figure 14. Global Buprenorphine Patches Sales (K Units), 2021–2032
Figure 15. Global Buprenorphine Patches Average Price (US$/Unit), 2021–2032
Figure 16. Buprenorphine Patches Report Years Considered
Figure 17. Buprenorphine Patches Sales Share by Manufacturers in 2025
Figure 18. Global Buprenorphine Patches Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Buprenorphine Patches Players: Market Share by Revenue in Buprenorphine Patches in 2025
Figure 20. Buprenorphine Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Buprenorphine Patches Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Buprenorphine Patches Sales Market Share by Country (2021–2032)
Figure 23. North America Buprenorphine Patches Revenue Market Share by Country (2021–2032)
Figure 24. United States Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Buprenorphine Patches Sales Market Share by Country (2021–2032)
Figure 27. Europe Buprenorphine Patches Revenue Market Share by Country (2021–2032)
Figure 28. Germany Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Buprenorphine Patches Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Buprenorphine Patches Revenue Market Share by Region (2021–2032)
Figure 35. China Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Buprenorphine Patches Sales Market Share by Country (2021–2032)
Figure 43. Latin America Buprenorphine Patches Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Buprenorphine Patches Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Buprenorphine Patches Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Buprenorphine Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Buprenorphine Patches by Type (2021–2032)
Figure 54. Global Revenue Market Share of Buprenorphine Patches by Type (2021–2032)
Figure 55. Global Buprenorphine Patches Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Buprenorphine Patches by Application (2021–2032)
Figure 57. Global Revenue Market Share of Buprenorphine Patches by Application (2021–2032)
Figure 58. Global Buprenorphine Patches Price (US$/Unit) by Application (2021–2032)
Figure 59. Buprenorphine Patches Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232